Malamut Richard 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Malamut Richard
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2022-02-10+36,750→ 130,308 total - Tax Payment
Common Stock
2022-02-10$17.63/sh−4,462$78,665→ 132,102 total - Award
Common Stock
2022-02-10+6,256→ 136,564 total - Tax Payment
Common Stock
2022-02-10$17.63/sh−1,838$32,404→ 130,264 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
- [F2]On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 6,256 performance share units granted in the issuer's two prior fiscal years.
- [F3]Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F4]Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.